Ubaldi L[au] - Search Results

Year	Number of Results
2004	1
2017	1
2021	3
2022	1
2023	2

1

One dose of SARS-CoV-2 vaccine exponentially increases antibodies in individuals who have recovered from symptomatic COVID-19.

Levi R, Azzolini E, Pozzi C, Ubaldi L, Lagioia M, Mantovani A, Rescigno M. Levi R, et al. Among authors: ubaldi l. J Clin Invest. 2021 Jun 15;131(12):e149154. doi: 10.1172/JCI149154. J Clin Invest. 2021. PMID: 33956667 Free PMC article. Clinical Trial.

2

A 'Multiomic' Approach of Saliva Metabolomics, Microbiota, and Serum Biomarkers to Assess the Need of Hospitalization in Coronavirus Disease 2019.

Pozzi C, Levi R, Braga D, Carli F, Darwich A, Spadoni I, Oresta B, Dioguardi CC, Peano C, Ubaldi L, Angelotti G, Bottazzi B, Garlanda C, Desai A, Voza A, Azzolini E, Cecconi M; ICH COVID-19 Task-force; Mantovani A, Penna G, Barbieri R, Politi LS, Rescigno M. Pozzi C, et al. Among authors: ubaldi l. Gastro Hep Adv. 2022;1(2):194-209. doi: 10.1016/j.gastha.2021.12.006. Epub 2022 Feb 7. Gastro Hep Adv. 2022. PMID: 35174369 Free PMC article.

3

Adverse Events to Comirnaty Vaccine Are Linked to Sex, Age and BMI: Should We Consider Reducing the Dose for Females?

Azzolini E, Mollura M, Pozzi C, Ubaldi L, Mantovani A, Selmi C, Barbieri R, Rescigno M. Azzolini E, et al. Among authors: ubaldi l. Vaccines (Basel). 2023 Feb 22;11(3):505. doi: 10.3390/vaccines11030505. Vaccines (Basel). 2023. PMID: 36992089 Free PMC article.

4

The antibody response to SARS-CoV-2 infection persists over at least 8 months in symptomatic patients.

Levi R, Ubaldi L, Pozzi C, Angelotti G, Sandri MT, Azzolini E, Salvatici M, Savevski V, Mantovani A, Rescigno M. Levi R, et al. Among authors: ubaldi l. Commun Med (Lond). 2021;1(1):32. doi: 10.1038/s43856-021-00032-0. Epub 2021 Sep 17. Commun Med (Lond). 2021. PMID: 35072166 Free PMC article.

5

Deriving quantitative information from multiparametric MRI via Radiomics: Evaluation of the robustness and predictive value of radiomic features in the discrimination of low-grade versus high-grade gliomas with machine learning.

Ubaldi L, Saponaro S, Giuliano A, Talamonti C, Retico A. Ubaldi L, et al. Phys Med. 2023 Mar;107:102538. doi: 10.1016/j.ejmp.2023.102538. Epub 2023 Feb 14. Phys Med. 2023. PMID: 36796177

6

Strategies to develop radiomics and machine learning models for lung cancer stage and histology prediction using small data samples.

Ubaldi L, Valenti V, Borgese RF, Collura G, Fantacci ME, Ferrera G, Iacoviello G, Abbate BF, Laruina F, Tripoli A, Retico A, Marrale M. Ubaldi L, et al. Phys Med. 2021 Oct;90:13-22. doi: 10.1016/j.ejmp.2021.08.015. Epub 2021 Sep 11. Phys Med. 2021. PMID: 34521016 Free article.

7

Accidental Peccei-Quinn Symmetry Protected to Arbitrary Order.

Di Luzio L, Nardi E, Ubaldi L. Di Luzio L, et al. Among authors: ubaldi l. Phys Rev Lett. 2017 Jul 7;119(1):011801. doi: 10.1103/PhysRevLett.119.011801. Epub 2017 Jul 6. Phys Rev Lett. 2017. PMID: 28731754

8

Effects of a static magnetic field on cell growth and gene expression in Escherichia coli.

Potenza L, Ubaldi L, De Sanctis R, De Bellis R, Cucchiarini L, Dachà M. Potenza L, et al. Among authors: ubaldi l. Mutat Res. 2004 Jul 11;561(1-2):53-62. doi: 10.1016/j.mrgentox.2004.03.009. Mutat Res. 2004. PMID: 15238230

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

8 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year